This meeting took place in 2018

Here are the related meetings in 2020:
Hypoxia: Molecules, Mechanisms and Disease (A3)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Therapeutic Targeting of Hypoxia-Sensitive Pathways (V1)

Organizer(s) Chris W. Pugh, Pablo Wappner, Johanna Myllyharju and Moira K. Whyte
April 10—14, 2018
University of Oxford Mathematical Institute • Oxford, UK
Discounted Abstract Deadline: Dec 11, 2017
Abstract Deadline: Jan 10, 2018
Scholarship Deadline: Dec 11, 2017
Discounted Registration Deadline: Feb 13, 2018

Sponsored by Akebia Therapeutics

Summary of Meeting:
Tissue oxygen gradients contribute to morphogenesis and in health cells in different tissues function under differing ambient oxygen conditions. Diseases or environmental challenges can reduce oxygen supply or increase demand, resulting in tissue hypoxia. Adaptive mechanisms have evolved that range from almost instantaneous acute ventilatory changes, through transcriptional events entrained in hours, to epigenetic events with slower effects and genetic adaptations selected across species and over generations. The role of the 2-oxoglutarate dependent dioxygenase enzyme family in influencing many, but not all, of these pleiotropic processes is increasingly recognized, and drugs targeting these enzymes are being evaluated in both experimental and clinical settings. The conference aims to combine the Keystone Symposia brand with the European HypoxiaNET consortium to bring together experts in hypoxia biology from clinical, academic and industrial backgrounds, including trainees, to: 1) Address gaps in our knowledge of responses to hypoxia across these time-frames and in different tissues; 2) Benefit the field by sharing techniques and reagents to enhance therapeutic targeting of the hypoxic response in general, including via inhibition of oxygen-sensitive enzymes; 3) Consider the utility of harnessing these pathways in organ dysfunction, in regenerative medicine and to influence immune and inflammatory responses; and 4) Disseminate outcomes of ongoing clinical trials and enhance plans for future trials. The most important anticipated outcome from the conference is that, through sharing knowledge, enhancing collaborations and training participants from diverse backgrounds, the likelihood of successful manipulation of hypoxia pathways to produce clinical benefits in a variety of fields including, but not restricted to, renal anemia will be significantly enhanced.

View Meeting Program


National Heart, Lung, and Blood Institute (NHLBI) Scholarship Recipients

Michael Batie
University of Liverpool, UK

Tiffany M. Bernardo
University of Pittsburgh, USA

Franziska Dengler
University of Leipzig, Germany

James W. Fielding
Oxford University, UK

Kateryna Kubaichuk
University of Oulu, Finland

Tuomas Laukka
University of Oulu, Finland

David P. Marciano
Stanford University, USA

Ilaria Maria Cristina Orlando
University of Zurich, Switzerland

Ann-Helen Sigrid Rosendahl
University of Oulu, Finland

Amalia Ruiz-Serrano
University of Zürich, Switzerland

Manuel Alejandro Sánchez García
University of Seville, Spain

Sundary Sormendi
Medizinische Fakultät - TU Dresden, Germany